Interestingly, on the promoters of factors like IL6 and ADORA1, which are upregulated in cancers and are associated with poor prognosis, histone acetylation was found to be significantly repressed upon luteolin treatment (Figure 4C). The gene discussed is ADORA1; the disease is cancer.